|
Bausch & Lomb Names Evon L. Jones Corporate Vice President and Chief Information Officer
 Bausch & Lomb has named Evon L. Jones corporate vice president and chief information officer, responsible for all Information Technology services at the eye health company.
Dr. Tung, 46, joins Bausch & Lomb from Boston Scientific Corporation in Natick, Mass., where he has been vice president - New Business Development since 2000. At Boston Scientific, Tung evaluated numerous healthcare technologies, led multi-functional due diligence efforts, closed multiple international transactions and developed strong relationships with key physicians, executives, entrepreneurs and healthcare industry leaders. In addition, he played a lead role in the development and execution of the corporate biopharma business strategy.
"Dr. Henry Tung's extensive experience in developing and assessing strategies for healthcare and medical device companies will be a real asset to our surgical businesses," said Ronald L. Zarrella, Bausch & Lomb chairman and chief executive officer. "We're very pleased to welcome him to Bausch & Lomb."
Prior to Boston Scientific, Tung was a consultant at McKinsey & Company, specializing in work with pharmaceutical and medical technology healthcare clients. Client work included growth strategies and research and development strategies. From 1991-97, he was a partner at Anesthesia Services Medical Group in San Diego, the largest single-specialty medical group in the U.S. with more than 150 physicians, where he was a member of the board of directors.
Tung holds a M.D. from the University of California San Diego School of Medicine; a M.B.A. in Finance and Healthcare Management from the J.L. Kellogg Graduate School of Management at Northwestern University in Evanston, Illinois; and a B.A. degree in Human Biology from Stanford University in Palo Alto, Calif.
He succeeds Kamal K. Sarbadhikari, 62, who plans to retire in 2005 after nearly 20 years at the Company.
"Kamal Sarbadhikari's contributions to Bausch & Lomb cannot be overestimated," said Zarrella. "He has played significant roles in research and development for contact lenses, lens care, implantable devices and equipment, as well as in Quality and Regulatory Affairs. Most recently, he led the Company's efforts to build a bright future for our surgical businesses."
|
